The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model
- 9 November 2007
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 210 (1) , 154-163
- https://doi.org/10.1016/j.expneurol.2007.10.015
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Low brain‐derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patientsAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2007
- Limbic neurogenesis/plasticity in the R6/2 mouse model of Huntington's diseaseNeuroReport, 2006
- Abnormalities of Neurogenesis in the R6/2 Mouse Model of Huntington's Disease Are Attributable to theIn VivoMicroenvironmentJournal of Neuroscience, 2005
- Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease miceNeurobiology of Disease, 2005
- Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's DiseaseJournal of Neuroscience, 2004
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- AAV-Mediated gene delivery of BDNF or GDNF is neuroprotective in a model of huntington diseaseMolecular Therapy, 2004
- Decreased hippocampal cell proliferation in R6/1 Huntington’s miceNeuroReport, 2004
- Brain-Derived Neurotrophic Factor-Mediated Protection of Striatal Neurons in an Excitotoxic Rat Model of Huntington's Disease, as Demonstrated by Adenoviral Gene TransferHuman Gene Therapy, 1999
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997